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Abstract
Many scientific questions require estimating the effects of continuous treatments.
Outcome modeling and weighted regression based on the generalized propensity score
are the most commonly used methods to evaluate continuous effects. However, these
techniques may be sensitive to model misspecification, extreme weights or both. In
this paper, we propose Kernel Optimal Orthogonality Weighting (KOOW), a con-
vex optimization-based method, for estimating the effects of continuous treatments.
KOOW finds weights that minimize the worst-case penalized functional covariance
between the continuous treatment and the confounders. By minimizing this quan-
tity, KOOW successfully provides weights that orthogonalize confounders and the
continuous treatment, thus providing optimal covariate balance, while controlling for
∗Corresponding author. This material is based upon work supported by the National Science Foundation
under Grants Nos. 1656996 and 1740822.
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extreme weights. We valuate its comparative performance in a simulation study. Us-
ing data from the Women’s Health Initiative observational study, we apply KOOW
to evaluate the effect of red meat consumption on blood pressure.
Keywords: Independence, continuous actions, policy evaluation, causal inference, optimiza-
tion, covariate balance
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1 Introduction
The questions that motivate many scientific studies require estimating the effects of contin-
uous treatments. Continuous treatments are usually indexed by doses and their relation-
ships with the outcome are described by dose-response curves. Consider, for instance, an
observational study that aim at evaluating the relationship between red meat consumption
and health outcomes such as high blood pressure, and cancer development. In this study,
the amount of red meat that a person eats every day (dose in grams) is the continuous
treatment under study, while the response is the person’s blood pressure or probability of
developing cancer. The medical literature on this topic is vast and it has shown that high
red meat consumption may be harmful, leading to suggested levels of red meat consumption
between 350 and 500 grams per week (World Research Cancer Fund, 2018).
Common methods used to evaluate continuous effects are 1) outcome modeling, which
first computes the regression function of the observed outcome on both the observed con-
tinuous treatment and the confounders and then takes its expectation over the confounders
(Flores et al., 2007; Florens et al., 2008; Bia et al., 2011), and 2) methods based on the
generalized propensity score (GPS) (Hirano and Imbens, 2004; Imai and Van Dyk, 2004)
such as for example Inverse Probability Weighting (IPW) (Naimi et al., 2014; Robins, 2000;
Cole and Herna´n, 2008). These methods rely on the correct specification of the outcome or
GPS-model, respectively, which assumption is hardly ever met in any observational study.
In addition, when using IPW-based methods, weights can be extreme leading to erroneous
inferences (Kang et al., 2007). Many other methods have been developed and we review
them in Section 1.1.
In this paper, rather than using outcome modeling or the GPS, we propose Kernel Op-
timal Orthogonality Weighting (KOOW), a novel method that optimally finds weights that
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minimize the worst-case penalized functional covariance between the continuous treatment
and the confounders. KOOW aims at eliminating any relationship between confounders and
the continuous treatment, thus providing optimal covariate balance. To do so, in Section
2 we start by proposing a functional formulation of the covariance between the continu-
ous treatment and the confounders. We then define the penalized worst-case functional
covariance and use kernels and quadratic programming to find the weights that minimize
this quantity. Finally, for estimating the dose-response curve, we propose to plug-in the
obtained optimal weights into a nonlinear weighted ordinary least squares estimator or a
weighted local polynomial regression estimator. We describe the properties of the proposed
methodology and provide practical guidelines on its use in Section 2.5 and Section 3, re-
spectively. In Section 4, we report the results of a simulation study aimed at valuating the
performance of KOOW in a variety of different scenarios. We apply the proposed method-
ology on the evaluation of red meat consumption on blood pressure among women of the
Women Health Initiative observational study (Section 5). We conclude with some remarks
in Section 6.
1.1 Related work
In practice, one of the most common method used to evaluate continuous effects is outcome
modeling, which directly models the relationship between the outcome, the treatment and
confounders (Flores et al., 2007), (Hill, 2011, Section 6.2), (Zhang et al., 2016, Section
3.1). Methods based on the GPS have been proposed. Hirano and Imbens (2004); Imai
and Van Dyk (2004) suggested to use an outcome model conditioned on the estimated
GPS. Lu et al. (2011, 2001) proposed matching on the GPS using a non-bipartite matching
algorithm. More recently, Wu et al. (2018) developed an new approach for GPS caliper
matching. IPW-based methods, such as Marginal Structural Models (MSM) (Robins, 2000;
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Cole and Herna´n, 2008) have been extended in the case of continuous treatments (Naimi
et al., 2014; Gill and Robins, 2001; Zhang et al., 2016). A variety of methods have been pro-
posed to estimate the GPS. Zhu et al. (2015) proposed a boosting algorithm for estimating
GPS. Kreif et al. (2015) suggested to use Super Learner (Van Der Laan and Dudoit, 2003)
for both the GPS and the outcome models. More generally, Kennedy et al. (2017) devel-
oped a nonparametric doubly robust estimator for estimating dose-response curves. When
the estimated GPS is very close to zero or one, which in the case of a continuous treatment
is inevitable, the corresponding obtained weights can be very extreme leading to erroneous
inferences (Kang et al., 2007). Methods have been proposed to overcome the issue of ex-
treme weights (Santacatterina and Bottai, 2018; Cole and Herna´n, 2008; Xiao et al., 2013,
among others). Methods that target covariate balance have been recently developed. Fong
et al. (2018) extended the covariate balancing propensity score methodology to continuous
treatment by developing both a parametric and a nonparametric version of the method.
Yiu and Su (2018) introduced a general framework based on a constrained optimization
problem that find weights that eliminate the relationship between the continuous treat-
ment and the covariates. Arbour and Dimmery (2019) introduced permutation weighting,
which finds weights based on density-ratio estimation via probabilistic classification. The
computer science and optimization literature has been also proposing novel methods. For
example, see Kallus and Zhou (2018); Sondhi et al. (2019); Krishnamurthy et al. (2019) for
policy evaluation, and Demirer et al. (2019) for policy learning with continuous actions.
Other methods include that of Galvao and Wang (2015) in which a semiparametric two-
step estimator for estimating the dose-response function is proposed, and the extension of
the G-computation (Robins, 1986) methodology to continuous treatments (Neugebauer and
van der Laan, 2006; Gill, 2004). Methods have been proposed to estimate effects of con-
tinuous treatments in a variety of different setting, such as quantile continuous treatment
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effects (Alejo et al., 2018), difference-in-differences in repeated cross sections with con-
tinuous treatments (d’Haultfoeuille et al., 2013), optimal dynamic continuous treatment
regimes (Barrett et al., 2014), and dose-response function for longitudinal data (Moodie
and Stephens, 2012). Finally, our methods builds upon some results on kernel methods for
testing the independence of two random variables (Gretton et al., 2005, 2007), and ker-
nel mean matching for density-ratio estimation (Huang et al., 2007; Gretton et al., 2009)
(Sugiyama et al., 2012, Section 3.3).
Our main contribution relative to this body of work is to provide a general and intuitive
balancing approach based on conventional optimization techniques to estimating effects of
continuous treatments.
2 Kernel Optimal Orthogonality Weighting
In this Section we present KOOW. We start by defining the functional covariance between
the continuous treatment and the confounders (Section 2.1). Since this quantity depends on
unknown functions, in Section 2.2, we define the worst-case functional covariance. Weights
that minimize this quantity may be extreme. In Section 2.2 we also add a penalization
term to control for extreme weights. In Section 2.3, by using kernels and standard results
from Reproducing Kernel Hilbert Spaces (RKHS), we find the set of weights that minimize
the worst-case penalized functional covariance by defining a linearly-constrained convex
optimization problem.
2.1 Functional covariance
Suppose we have a simple random sample with replacement of size n from a population.
For each unit i in 1, . . . , n let Xi and Ai be the observed confounder and treatment value.
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Let X1:n and A1:n denote all the observed confounders and treatment values. The main
idea is to find a set of weights that minimizes the following empirical functional covariance
between confounders X1:n and treatment A1:n. We define this quantity as,
δ(W1:n, f) =
1
n
n∑
i=1
Wif(Xi, Ai)− 1
n2
n∑
i=1
n∑
j=1
f(Xi, Aj), (2.1)
where f(x, a) is an unknown function that describe the relationship between the continuous
treatment and the confounders (here, a and x are just two dummy variables). Equation
(2.1) suggests finding weights that re-balance the joint distribution between treatment and
confounders to be the same as that of the product of the two distributions. We now provide
a straightforward example to clarify ideas. Figure 1 depicts the relationship between a nor-
mally distributed confounder X with mean 0 and variance 1, and a normally distributed
treatment A with mean X and unit variance. The straight line shows the relationship
between the two while the dots represent the values obtained for the two variables. The
darkness and the size of the circles represent the size of the weights, i.e., the darker/larger
the circle, the larger the weight. A set of weights that minimize eq. (2.1), weights more
those units with no relationship between the confounder and the continuous treatment
making them orthogonal. In other words, the obtained weights eliminate any associations
between the continuous treatment and the confounders, thus providing optimal covariate
balance. As a matter of fact, recent literature on GPS-based methods (Austin, 2019; Zhu
et al., 2015) suggests the use of correlation-based diagnostics, such as the weighted corre-
lation, to assess covariate balance. Our idea is not only to use this quantity as diagnostic
but actually to find the set of weights that minimize it.
.
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Figure 1: Scatterplot between a confounder and a continuous treatment. The size and the darkness of
the circles refer to the size of the weights that minimize eq (2.1).
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2.2 Worst-case penalized functional covariance
The functional covariance showed in equation 2.1, depends on the unknown function f . In
this Section, we propose to minimize the worst-case functional covariance normalized by
the magnitude of the function f . To do so, we start by embedding the function f into
a seminormed space with seminorm (a norm that can also assign the values 0 and ∞ to
nonzero elements), ‖ · ‖. We first define the normalized worst-case functional covariance as
∆(W1:n) = sup
f
δ(W1:n, f)
‖f‖ = sup‖f‖≤1 δ(W1:n, f), (2.2)
which can be seen as the dual norm of the continuous linear operator, δ(W1:n, f). In
particular, we consider the norm given by an RKHS, a Hilbert space of functions which is
associated with a positive semidefinite (PSD) kernel K(x, x′). Define the matrix K ∈ Rn×n
as Kij = K(Xi, Xj). Then, we have that
∆2(W1:n) = sup
‖f‖2≤1
(
1
n
n∑
i=1
Wif(Xi, Ai)− 1
n2
n∑
i=1
n∑
j=1
f(Xi, Aj)
)2
= sup∑n
i,k=1 αiαkK((Xi,Xk),(Ai,Ak))≤1
(
1
n
n∑
i=1
Wif(Xi, Ai)− 1
n2
n∑
i=1
n∑
j=1
f(Xi, Aj)
)2
(a)
= sup
αTKα≤1
(
1
n
α>K
(
W1:n − 1
n
en
))2
= ‖ 1
n
K
(
W1:n − 1
n
en
)
‖22 (b)
=
1
n2
((
W1:n − 1
n
en
)>
K
(
W1:n − 1
n
en
))
=
1
n2
(
W1:n
>KW1:n − 2
n
e>nKW1:n +
1
n2
e>nKen
)
,
where (a) is by the representer theorem (Scho¨lkopf et al., 2001), and (b) by the dual of the
Euclidean norm, and en is the vector with 1/n in every entry. This results shows that the
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worst case functional covariance can be expressed as a convex-quadratic function in W1:n.
To control for extreme weights we propose to add a penalization term and consider the
following worst-case penalized functional covariance,
C(W1:n, λ) = ∆
2(W1:n) +
λ
n2
‖W1:n‖22.
When λ equals zero, we obtain weights that minimize the covariance. When λ is set
to be large (depending on the data), we obtain uniform weights. We discuss choices of λ
in Section 3. In the next Section, we show how to use quadratic optimization to minimize
C(W1:n, λ).
2.3 Quadratic optimization to minimize C(W1:n, λ)
In the previous Sections we introduced a functional formulation of the covariance between
the continuous treatment and the confounders. Since this quantity depends on unknown
function we considered the worst-case functional covariance, which is the dual norm of
the continuous linear operator, δ (W1:n, f), showed that it can be expressed as a convex-
quadratic function in W1:n and defined the worst case penalized functional covariance,
which aim at penalizing extreme weights. We restric the weights to be positive and sum
up to one. Formally, we let W = {W1:n ∈ Rn : Wi ≥ 0 ∀i,
∑n
i=1Wi = 1}. We propose to
use weights W1:n obtained by solving the following optimization problem
min
W1:nW
C(W1:n, λ). (2.3)
As shown in Section 2.2, we can express C(W1:n, λ) as a convex-quadratic function in
W1:n, and therefore, optimization problem (2.3) reduces to the following linearly-constrained
convex-quadratic optimization problem,
min
W1:n≥0,
W>1:nen=n
1
n2
(
W1:n
>QW1:n − 2W1:n>c
)
, (2.4)
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where Q = K + Σλ, c = e
>
nK, and Σλ is the diagonal matrix with λ/n
2 in its ith diagonal
entry.
2.4 Dose-response curve
In addition to the data presented in Section 2.1, for each unit i in 1, . . . , n let Yi(a) be the
potential outcome of treatment a ∈ A, and Yi = Yi(Ai) the observed outcome. The main
object of inference in this paper is the dose-response curve θ(a) = E [Y (a)]. This quantity
depends on unknown potential outcomes, and assumptions are needed to identify it in terms
of observed data. In this paper we assume consistency, positivity and ignorability (Imbens
and Rubin, 2015). Consistency (together with non-interference) states that the observed
outcome equals the potential outcome under the treatment applied to that specific unit,
i.e., Yi = Yi(a), and that the potential outcomes are well-defined. Positivity states that, the
GPS is positive for all values of the confounders in their supports. Ignorability states that,
once conditioned on the observed confounders, the potential outcomes are independent
to the treatment assignment. Finally, under these assumption, it can be shown that the
dose-response curve θ(a) is identifiable using observational data.
In the previous Sections, we showed how to obtain weights that minimize the functional
covariance defined in (2.1) by simply solving a linearly-constrained quadratic optimization
problem. As described in Section 2.1, these weightseliminate any associations between the
continuous treatment and the confounders, thus providing optimal covariate balance. Once
these weights are obtained, to estimate the dose-response curve, we suggest plugging these
weights into a weighted parametric or nonparametric estimator. For instance, similar to
the approach of Naimi et al. (2014); Cole and Herna´n (2008) for estimating marginal struc-
tural models, one can use a weighted nonlinear regression or a weighted local polynomial
regression to estimate θ(a), regressing only the treatment on the outcome.
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2.5 Properties
In this Section, we provide some insights on the properties of dose-response curve estimators
weighted by KOOW weights. The overall idea of using weights that minimize the covariance
between treatment and confounders has been previously studied in the context of maximal
mean discrepancies (MMD) for density-ratio estimation or for testing independence of
random variables (Sugiyama et al., 2012; Gretton et al., 2005). In addition, it is also
been shown the connection between MMD and the more general Bregman divergence (see
(Sugiyama et al., 2012, Section 7.3.2)). As a consequence, existing results can be used
to describe the properties of our proposed methodology. Specifically, by following Sondhi
et al. (2019); Menon and Ong (2016); Arbour and Dimmery (2019), using kernel functions
(as in the local polynomial regression estimator) and under the assumption that exist a
set of “true” weights that minimize the bias of the weighted estimator, e.g.., the stable
inverse probability weights, we can bound the bias of the weighted estimator. For instance,
the bias of the weighted estimator is bounded by the Bregman distance between the true
weights and the weights obtained by solving the optimization problem plus a remainder
of a smaller order than the bandwidth parameter when this term goes to infinity (Sondhi
et al., 2019, Proposition 2). A similar bound is also provided for the variance (Sondhi
et al., 2019, Proposition 3). Furthermore, Sondhi et al. (2019) show that under bounded
variance, the weighted estimator is also consistent.
3 Practical guidelines
Solutions to the optimization problem (2.3) depend on the kernel specification, its hyperpa-
rameters and the penalization parameter λ. In this Section, we provide practical guidelines
on their choice. We start by describing the choice of the kernel. Since we want to allow for
12
a great level of flexibility in modeling the relationship between treatment and confounders,
we suggest the use of a product of polynomial Mahalanobis kernels:
K((a, x), (a′, x′)) = K1(a, a′)K2(x, x′), (3.1)
where
Kt(z, z′) = γt(1 + θt(z − µˆn)T Σˆ−1n (z′ − µˆn))d, (3.2)
and where γt controls the overall scale of the kernel, θt is a parameter that controls the
importance of higher orders degrees, Σˆn is the sample covariance, µˆn is the sample mean,
and d is the parameter that controls the degree of the polynomial. Gretton et al. (2005)
showed that by using universal kernels, such as the Gaussian and Mate´rn kernels, minimiz-
ing (2.3) leads to statistically independence, whereas by using non-universal kernels, such
as polynomial kernels, we aim at uncorrelatedness. Although independence may be pre-
ferred over uncorrelatedness, we find that practically polynomial kernels suffice as shown
in our simulations (Section 4) and in our illustration (Section 5) .
We now provide practical guidelines on how to tune the kernel’s hyperparameters and
the penalization parameter λ. As shown by Kallus et al. (2018); Kallus and Santacatte-
rina (2018), we suggest using marginal likelihood, a model selection criteria for Gaussian
processes (Rasmussen and Nickisch, 2010). To do so, we specify a Gaussian Process (GP)
prior, f with covariance identified by the product kernel K, and suppose that we observed
the potential outcome Yi(a) from f(Xi) with Gaussian noise of variance σ
2. We then maxi-
mize the marginal likelihood of seeing the data with respect to the hyperparameters, θt, γt,
and σ2. The penalization parameter λ can be interpreted as a uncorrelatedness-precision
(bias-variance) trade-off parameter. When set to 0, the obtained weights targets minimal
covariance and therefore minimal bias. When λ increases, the obtained weights have lower
variance and higher precision can be consequently achieved. An example is provided in
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Figure 2, in which we plot the scatterplots between a confounder (X-axes) and a treatment
(Y-axes) weighted by the set of weights obtained by solving the optimization problem (2.3),
setting λ equal to 0 (first panel from the left of Figure 2), 1 (second panel), 10 (third panel)
and 100 (fourth panel). When increasing the penalization parameter λ, it is clear from this
Figure that the distribution of the weights become more uniform (bottom of each scat-
terplot) thus achieving less uncorrelatedness but increasing precision. In practical setting,
an acceptable level of penalization, and therefore of precision, may be for the analyst to
determine. We suggest, starting by lower values and, in case, trying to explore different
values within reason. We show this in our simulations in Section 4.
To estimate standard errors of the dose-response curve, we suggest using bootstrap.
Specifically, we suggest to bootstrap the whole process, namely the estimation of the
weights, and that of the dose-response curve by a weighted estimator, as shown in our
simulation study.
To tune hyperparameters and solve linearly-constrained convex-quadratic optimization
problems several software can be used. We suggest using the GaussianProcessRegressor
package from scikit-learn (Pedregosa et al., 2011) for tuning the hyperparameters and Gurobi
(Gurobi Optimization, 2014) for solving quadratic optimization problems.
4 Simulations
In this Section, we present the results of a simulation study aimed at evaluating the per-
formance, in terms of integrated absolute bias (IAB) and integrated root mean squared
error (IRMSE) across several simulation scenarios. In summary, KOOW performed well
with respect to integrated absolute bias and integrated root mean squared error, across the
considered scenarios and regardless of the use of a parametric or a nonparametric model
14
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Figure 2: The uncorrelatedness-precision trade-off when increasing the value of the penalization parameter
λ from 0 (first panel from the left) to 100 (last panel from the left). Confounder on the X-axes, Treatment
on the Y-Axes.
for the dose-response curve.
4.1 Setup
We considered a sample size of n = 1, 000. We generated
Yi = 0.75Ai + 0.05A
2
i + 0.01A
3
i + 1.5(
5∑
k=1
Xk,i) + 1.125Ai(
5∑
k=1
Xk,i),
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and considered three scenarios for the treatment mechanism: linear, quadratic and cubic.
Specifically, we generated
Ai = β0 + β1(
5∑
k=1
Xk,i)
d +N (0, 5)
where β0 = (0,−3,−2.5), β1 = (1, 0.25, 0.05) and d = (1, 2, 3), for the linear, quadratic
and cubic scenario, respectively, and Xk,i ∼ N (0, 5), k = 1, . . . , 5. We generated the true
dose-response curves by evaluating the true models at a grid of 1,000 values from -3 to 3.
We compared KOOW with, outcome modeling (OM) (Flores et al., 2007), the non para-
metric doubly robust estimator of Kennedy et al. (2017) (NPDR), matching on the gen-
eralized propensity score (CM) (Wu et al., 2018), (stable) inverse probability of treatment
weighting (IPW) (Naimi et al., 2014), parametric (CBPS) and nonparametric covariate
balancing propensity score (npCBPS) (Fong et al., 2018). We used Super Learner (Van der
Laan et al., 2007) to model the relationships between the outcome the treatment and the
confounders (the outcome model) and to model the relationship between the continuous
treatment and the confounders (treatment model) for OM, NPDR, and IPW. We consid-
ered the following list of algorithms for the Super Learner: linear model, linear model with
interactions, linear model with lasso penalization, generalized additive models, multivari-
ate adaptive regression splines, bayesian linear model, and local polynomial regression. For
KOOW, we considered λ = 0, 1 and 10.
We estimated the dose-response curve by using a local polynomial regression estimator
with degree 2 and a cubic parametric regression estimator for all methods. Specifically,
for KOOW, IPW, CBPS, and npCBPS we plugged the obtained weights into the local
polynomial and cubic parametric regression estimators. For OM, NPDR, and CM, we re-
gressed the treatment on the “pseudo” outcomes. We compared KOOW with the other
methods with respect to IAB and IRMSE defined as in (Kennedy et al., 2017; Wu et al.,
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2018, Section 4 and Section 5.1, respectively). We used scikit-learn (via the R package
reticulate) to tune the hyperparametes of the GPs, the R interface of Gurobi to obtain the
set of KOOW weights, the R package SuperLearner for computing the outcome and treat-
ment models, and the R package loess and glm for local polynomial and cubic parametric
regression estimation.
4.2 Results
In this Section we discuss the results of our simulation study. In summary, KOOW per-
formed well with respect to IAB and IRMSE across all three considered scenarios and
regardeless of the model used to estimate the dose-response curve (local polynomial or cu-
bic regression). Specifically, as shown in Table 1, when using a local polynomial regression
model, KOOW (λ = 0) obtained the lowest IAB across all scenarios. While OM, NPDR
and IPW performed well with respect to IAB and IRMSE under the linear scenario (linear
treatment mechanism - first column of Table 1), their performance deteriorated when in-
creasing the complexity of the treatment mechanism (second and third columns of Table 1).
For instance, NPDR had an IAB of 0.49 under the linear scenario, increasing to 3.18 in the
quadratic scenario and to 50.58 in the cubic scenario. CM performed relatively well only
in the quadratic scenario. CBPS and npCBPS performed well across the three scenarios,
suggesting that methods that target balance may have good performance when estimating
the effects of continuous treatments. It is worth mentioning that across all scenarios, the
IAB of KOOW slightly increased when increasing the penalization parameter λ, while the
IRMSE significantly decreased. This suggests that KOOW was able to improve precision
while introducing negligible bias by penalization.
We obtained similar results for KOOW, OM, NPDR, IPW and CM when estimating
the dose-response curve with a cubic parametric model (Table 2). CBPS and npCBPS
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performed worse compared to themselves when estimating the dose-response curve with a
local polynomial regression. The IAB of KOOW in the quadratic scenario (second colum
of Table 2) decreased while increasing the penalization parameter λ from 0 to 10 which is
in contrast to the results of all the other scenarios. We argue that this result is related to
this specific scenario and is heuristically explained by the fact that increasing precision by
penalization leads to less erroneous estimates and consequently less biased results. Figures
5,6,7 in the Supplementary Material show boxplots of the estimated linear (top-left panels),
quadratic (top-right panels), and cubic (bottom-left panels) coefficients of the cubic para-
metric model for the dose-response curve around their true values (horizontal lines) for all
the methods and across scenarios (linear, quadratic and cubic). As suggested by the results
in Table 2, KOOW, performed well across scenarios and for all coefficients. Specifically,
the interquantile ranges of KOOW’s boxplots almost always included the true coefficient.
18
Table 1: Integrated Absolute Bias (IAB) and integrated root MSE (IRMSE) across scenar-
ios when estimating the dose-response curve with a local polynomial regression estimator
degree 2
Treatment mechanism
Linear Quadratic Cubic
IAB (IRMSE)
Methods
KOOW λ = 0 0.46 (2.25) 0.19 (2.83) 0.34 (1.97)
KOOW λ = 1 0.51 (1.93) 0.21 (2.25) 0.38 (1.75)
KOOW λ = 10 0.67 (1.50) 0.23 (1.38) 0.59 (1.36)
OM 1.32 (1.48) 4.54 (5.78) 17.07 (35.28)
NPDR 0.49 (0.94) 3.18 (4.74) 50.58 (157.58)
IPW 0.50 (2.04) 0.37 (1.06) 3.87 (4.55)
CM 9.75 (10.80) 1.64 (5.78) 27.67 (28.14)
CBPS 0.67 (4.56) 0.44 (0.79) 0.56 (2.62)
npCBPS 0.98 (2.61) 0.73 (1.00) 1.53 (2.43)
Notes: KOOW refers to Kernel Optimal Orthogonality Weighting where
λ is the penalization parameter; OM refers to Outcome Modeling; NPDR
refers to Non Parametric Doubly Robust; IPW to (stable) Inverse Prob-
ability Weighting; CM to caliper matching for continuous treatment;
CBPS and npCBPS to parametric and non parametric Covariate Balanc-
ing Propensity Score. We used Super Learner to model the outcome and
treatment models for NPDR, IPW and OM.
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Table 2: Integrated Absolute Bias (IAB) and integrated root MSE (IRMSE) across scenar-
ios when estimating the dose-response curve with a cubic parametric regression
Treatment mechanism
Linear Quadratic Cubic
IAB (IRMSE)
Methods
KOOW λ = 0 0.46 (2.44) 0.28 (4.88) 0.13 (2.23)
KOOW λ = 1 0.51 (2.10) 0.10 (3.46) 0.15 (1.95)
KOOW λ = 10 0.71 (1.61) 0.07 (1.95) 0.27 (1.48)
OM 2.93 (3.00) 4.53 (5.78) 20.26 (36.01)
NPDR 0.14 (1.00) 1.01 (5.92) 7.36 (72.98)
IPW 1.77 (3.36) 0.89 (3.94) 3.85 (4.90)
CM 1.55 (8.41) 4.99 (34.48) 42.80 (44.92)
CBPS 2.51 (5.46) 3.24 (7.04) 3.15 (5.81)
npCBPS 6.98 (7.67) 1.51 (7.16) 12.45 (12.66)
Notes: KOOW refers to Kernel Optimal Orthogonality Weighting where
λ is the penalization parameter; OM refers to Outcome Modeling; NPDR
refers to Non Parametric Doubly Robust; IPW to (stable) Inverse Prob-
ability Weighting; CM to caliper matching for continuous treatment;
CBPS and npCBPS to parametric and non parametric Covariate Bal-
ancing Propensity Score. We used Super Learner to model the outcome
and treatment models for NPDR, IPW and OM.
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5 Case-study
In this Section, we apply KOOW to the evaluation of the effect of red meat consumption
on blood pressure among women of the Women’s Health Initiative (WHI) observational
study.
5.1 The effect of red meat consumption on hypertension among
women of the WHI observational study
Despite increasing efforts to early detect and treat high blood pressure in recent years,
hypertension still remains one of the major risk factor for stroke, cardiovascular diseases
and mortality worldwide (Wang and Wang, 2004; Lawes et al., 2006; Collaboration et al.,
2002). In the eighties, the “iron-heart” hypothesis (Sullivan, 1981) was proposed to explain
possible differences in rates of coronary heart disease between pre-menopausal women and
men. This hypothesis, was based on the idea that pre-menopausal women loose iron through
menstruation. Since these results, several studies have evaluated the relationship between
iron and coronary heart disease suggesting that greater haem iron (the iron originated from
animal sources) intake increases the risk of coronary heart disease (Wang et al., 2016, for
a recent meta-analysis). Red meat is a major source of haem iron and several studies
and guidelines suggest consuming a modest amount of red meat. Most of these studies
categorize red meat consumption in two or few categories and evaluate their effects on a
binary outcome, such as presence or not of hypertension (see Kappeler et al. (2013) for
example). However, as described in Section 1, a more natural object of interest is the dose-
response curve, which directly evaluates the amount of red meat that a person eats every
day on a continuous outcome. Therefore, in this Section we apply KOOW to estimate the
dose-response curve of red meat consumption and systolic blood pressure.
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5.2 Study population
We used a subset of 2,000 randomly selected units from the the Womens Health Initia-
tive (WHI) observational study (Study et al., 1998). WHI is one of the largest cohort
of postmenopausal women aged 50 to 79 years that provides valuable information about
demographic and clinical information such as data on blood pressure and hormone therapy
treatment. Red meat consumption was recorded as estimated medium servings per day.
We restricted our analyses to those women between the 5th and the 95th quantile of the
distribution of red meat consumption. Thus, the minimum medium red meat serving per
day in our subset was equal to 0.04, the mean 0.53, and the maximum 1.51. We identi-
fied as potential confounders the following variables: systolic blood pressure at baseline,
age, total dietary energy intake (measure in kcal), body mass index (BMI) (calculated as
weight in kilograms divided by the square of height in meters), smoking status (defined
as if a woman ever smoked at least 100 cigarettes), and hormone therapy (HT) ever used
(defined as if a woman ever used HT).
5.3 Model setup
We obtained the set of KOOW weights by solving optimization problem 2.3. We set λ
equal to 10. We chose a product of two polynomial kernel degree 1, and we tuned their
hyperparameters by using GPML as described in Section 4. We estimated the dose-response
curve by using a local polynomial regression estimator degree 1 weighted by the set of
KOOW weights. We bootstrapped the whole process of obtaining the KOOW weights and
estimating the dose-response curve, 1000 times. For each bootstrap sample, we computed
the predicted dose-response curve and finally estimated its bootstrap confidence interval.
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5.4 Results
In this Section we present the results of our analysis. Similar to the results of previous
studies we show a possible association between red meat consumption and hypertension.
Figure 3, shows the dose response curve between red meat consumption (x-axis) and the
systolic blood pressure (y-axis). Mean systolic blood pressure was around 125 for those
women with low medium red meat consumption, while increasing, up to almost 175, along
with the consumption of red meat. The top left panel of Figure 4 shows adjusted, i.e..,
weighted by the KOOW weights, covariate balance (black dots) and unadjusted (grey
dots) of the six confounders considered in our analysis. Covariate balance was computed as
the absolute weighted correlation between the continuous treatment and the confounders.
KOOW shows to minimize covariate balance to values close to 0. Figure 4 also shows the
scatterplots between each of the six considered confounders (x-axes of the top right panel
and the middle and bottom panels of Figure 4), and red meat consumption (y-axes). As
shown in Figure 1 in Section 2.1, KOOW provide weights that make confounders and red
meat consumption orthogonal. For completeness we also report the weighted units for the
binary confounders smoked and hormone therapy in the bottom panels of Figure 4. Finally,
based on the results of our analysis and similar to previous epidemiological and medical
literature, we conclude that there may be a possible positive relationship between red meat
consumption and systolic blood pressure.
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Figure 3: Estimated dose-response curve between red meat consumption (x-axis) and Systolic blood
pressure (y-axis). Confidence intervals are obtained by bootstrap (1,000 replications).
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Figure 4: Top left panel: absolute weighted correlation between the continuous treatment and the
confounders. Other panels show the relationship between the confounders (baseline systolic blood pressure,
dietary energy, BMI, age, smoking status and HT) and red meat consumption, reweighted by the set of
KOOW weights (size and color represent the weights, larger and darker units represent higher weights).
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6 Conclusion
Continuous treatments arises very often in practice and proper estimation of dose-response
curves is crucial for medical decision making. In this paper we proposed a novel method
based on quadratic optimization that finds weights that minimize the covariance between
the continuous treatment and the confounders, thus eliminating any possible relationships
between the two and consequently optimizing covariate balance.
By using kernels, the proposed method automatically learns the structure of the data
without relying on parametric assumptions about the outcome model, which, in most prac-
tical settings, are hardly ever met. In addition, as shown in Section 3, the penalization
parameter λ can be easily tuned and interpreted as the uncorrelatedness-precision (bias-
variance) trade-off parameter. The proposed method provided low integrated absolute bias
and low integrated RMSE across several different scenario, as showed in our simulation
scenarios,
In this paper, we tuned the kernels’ hyperparametes by using Gaussian Process Marginal
Likelihood. Other methods may be also used. For instance, one can use a kernelized
regression and tune the kernels hyperparameters by usual cross validation techniques.
In this paper, once the set of weights was obtained, we plugged it into a weighted
estimator for the dose-response curve. Alternative weighted estimation techniques may
also be considered. For instance, one may first estimate the KOOW weights and the plug
them into a parametric or nonparametric augmented estimator, similar to that of Kennedy
et al. (2017). Another option would be to use a KOOW-weighted regression estimator that
includes both treatment and confounders as in (Kang et al., 2007, Section 3.2).
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SUPPLEMENTARY MATERIAL
Simulations: Additional Figures5,6,7 showing the boxplots of the estimated linear (top-
left panels),quadratic (top-right panels), and cubic (bottom-left panels) coefficients
of the cubic para-metric model for the dose-response curve around their true values
(horizontal lines) for all the methods and across scenario.
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Figure 5: Linear Scenario: Boxplots of the estimated linear (top-left panel), quadratic (top-right panel),
and cubic (bottom-left panel) coefficients of the cubic parametric model for the dose-response curve around
their true values (horizontal lines) for all the methods under the linear scenario.
35
Quadratic Scenario
−
4
−
2
0
2
4
Linear term
KO
OW
 λ=
0
KO
OW
 λ=
1
KO
OW
 λ=
10 PM
NP
DR CM IPWCP
BS
npC
BP
S
−
0.
2
−
0.
1
0.
0
0.
1
0.
2 Cubic term
KO
OW
 λ=
0
KO
OW
 λ=
1
KO
OW
 λ=
10 PM
NP
DR CM IPWCP
BS
npC
BP
S
−
1.
0
−
0.
5
0.
0
0.
5
1.
0 Quadratic term
KO
OW
 λ=
0
KO
OW
 λ=
1
KO
OW
 λ=
10 PM
NP
DR CM IPWCP
BS
npC
BP
S
Figure 6: Quadratic Scenario: Boxplots of the estimated linear (top-left panel), quadratic (top-right
panel), and cubic (bottom-left panel) coefficients of the cubic parametric model for the dose-response
curve around their true values (horizontal lines) for all the methods under the quadratic scenario.
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Figure 7: Cubic Scenario: Boxplots of the estimated linear (top-left panel), quadratic (top-right panel),
and cubic (bottom-left panel) coefficients of the cubic parametric model for the dose-response curve around
their true values (horizontal lines) for all the methods under the cubic scenario.
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